Proefschrift

Antonarakis, E. (2011). Abiraterone acetate for prostate cancer: a new era of hormonal therapies. Asian Journal of Andrology , 13(5):663–664. 49 Antonarakis, E., Lu, C., Wang, H., Luber, B., Nakazawa, M., Roeser, J., Chen, Y., Mohammad, T., Chen, Y., Fedor, H., et al. (2014). AR-V7 and resistance to enzalutamide and abiraterone in prostate cancer. New England Journal of Medicine , 371(11):1028–1038. 113 Antonia, S., Mirza, N., Fricke, I., Chiappori, A., Thompson, P., Williams, N., Bepler, G., Simon, G., Janssen, W., Lee, J., et al. (2006). Combination of p53 cancer vaccine with chemotherapy in patients with extensive stage small cell lung cancer. Clinical Cancer Research , 12(3):878–887. 23 Archetti, M. (2013). Evolutionary game theory of growth factor production: implications for tumour heterogeneity and resistance to therapies. British Journal of Cancer , 109(4):1056– 1062. 82 Archetti, M., Ferraro, D., and Christofori, G. (2015). Heterogeneity for IGF-II production maintained by public goods dynamics in neuroendocrine pancreatic cancer. Proceedings of the National Academy of Sciences , 112(6):1833–1838. 82 Arena, S., Bellosillo, B., Siravegna, G., Mart´ınez, A., Can˜adas, I., Lazzari, L., Ferruz, N., Russo, M., Misale, S., Gonz´alez, I., et al. (2015). Emergence of multiple EGFR extracellular mutations during cetuximab treatment in colorectal cancer. Clinical Cancer Research , 21(9):2157–2166. 8 Attolini, C. and Michor, F. (2009). Evolutionary theory of cancer. Annals of the New York Academy of Sciences , 1168(1):23–51. 81 A¨ınseba, B. and Benosman, C. (2010). Optimal control for resistance and suboptimal response in CML. Mathematical Biosciences , 227(2):81–93. 14, 64 Bacevic, K., Noble, R., Soffar, A., et al. (2017). Spatial competition constrains resistance to targeted cancer therapy. Nature Commmunications , 8. 11, 23, 83 Bach, L., Bentzen, S., Alsner, J., and Christiansen, F. (2001). An evolutionary-game model of tumour–cell interactions: possible relevance to gene therapy. European Journal of Cancer , 37(16):2116–2120. 81 Ballehaninna, U. and Chamberlain, R. (2011). Serum CA 19-9 as a biomarker for pancreatic cancer—a comprehensive review. Indian Journal of Surgical Oncology , 2(2):88–100. 115 Bandrowski, A., Brush, M., Grethe, J., Haendel, M., Kennedy, D., Hill, S., Hof, P., Martone, M., Pols, M., Tan, S., et al. (2016). The resource identification initiative: A cultural shift in publishing. Neuroinformatics , 14(2):169–182. 29 Barzman, M., B`arberi, P., Birch, A., et al. (2015). Eight principles of integrated pest management. Agronomy for Sustainable Development , 35(4):1199–1215. 10, 19, 97 166